Dupilumab-induced psoriasiform paradoxical reactions in atopic dermatitis: clinical features, outcomes, and management
Anais Brasileiros de Dermatologia · 2026-11 · 101 (6) · 501494
DOI: 10.1016/j.abd.2026.501494 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-11. Verfasst von Yu-Lian Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
- Department of Dermatology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China. Electronic address: fangshengderm@163.com.
Zitieren
APA
Li, Y. L., & Fang, S. (2026). Dupilumab-induced psoriasiform paradoxical reactions in atopic dermatitis: clinical features, outcomes, and management. Anais Brasileiros de Dermatologia, 101(6), 501494. https://doi.org/10.1016/j.abd.2026.501494
Vancouver
Li YL, Fang S. Dupilumab-induced psoriasiform paradoxical reactions in atopic dermatitis: clinical features, outcomes, and management. Anais Brasileiros de Dermatologia. 2026;101(6):501494. doi:10.1016/j.abd.2026.501494
BibTeX
@article{Li2026,
author = {Li, Yu-Lian and Fang, Sheng},
title = {Dupilumab-induced psoriasiform paradoxical reactions in atopic dermatitis: clinical features, outcomes, and management},
journal = {Anais Brasileiros de Dermatologia},
year = {2026},
volume = {101},
number = {6},
pages = {501494},
doi = {10.1016/j.abd.2026.501494}
}
EUVIMED